Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-20,200
Closed -$132K 1333
2020
Q3
$132K Sell
20,200
-635,600
-97% -$4.71M ﹤0.01% 1177
2020
Q2
$5.29M Buy
655,800
+326,200
+99% +$2.31M 0.02% 600
2020
Q1
$1.96M Sell
329,600
-126,500
-28% -$2.12M 0.01% 740
2019
Q4
$10.2M Sell
456,100
-17,700
-4% -$392K 0.04% 447
2019
Q3
$10.6M Sell
473,800
-33,300
-7% -$783K 0.04% 458
2019
Q2
$11.3M Sell
507,100
-146,200
-22% -$3.13M 0.04% 441
2019
Q1
$14M Buy
653,300
+539,338
+473% +$12M 0.05% 381
2018
Q4
$2.47M Buy
113,962
+11,400
+11% +$276K 0.01% 778
2018
Q3
$2.67M Sell
102,562
-174,200
-63% -$4.47M 0.01% 821
2018
Q2
$6.82M Buy
276,762
+51,500
+23% +$1.19M 0.03% 565
2018
Q1
$4.83M Buy
225,262
+109,700
+95% +$2.35M 0.02% 665
2017
Q4
$2.37M Buy
115,562
+66,600
+136% +$1.28M 0.01% 816
2017
Q3
$886K Buy
+48,962
New +$950K ﹤0.01% 986
2017
Q1
Sell
-134,466
Closed -$3.35M 1314
2016
Q4
$3.35M Sell
134,466
-10,844
-7% -$278K 0.02% 654
2016
Q3
$4.09M Buy
145,310
+49,200
+51% +$1.37M 0.02% 607
2016
Q2
$2.58M Buy
+96,110
New +$2.7M 0.01% 698

Other funds holding SABR

Axa's SABR Position: Q4 2020 in Review

Axa sold out of Sabre (SABR) in Q4 2020, closing a stake of 20,200 shares — an estimated $132K sold.

Axa first reported a position in SABR in Q2 2016 and held it in 16 quarters. The position peaked at $14M in Q1 2019. 348 funds tracked by Wall St. Rank hold SABR as of Q4 2020.

  • Axa reported no remaining Sabre position as of Q4 2020 after selling out during the quarter.
  • Axa sold 20,200 Sabre shares in Q4 2020, an estimated $132K.
  • Axa first reported a position in Sabre in Q2 2016 and held it in 16 quarters.
  • Axa's Sabre position peaked at $14M in Q1 2019.
  • 348 funds tracked by Wall St. Rank held Sabre as of Q4 2020.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.